gga-mir-133a-3p Regulates Myoblasts Proliferation and Differentiation by Targeting PRRX1

gga-mir-133a-3p Regulates Myoblasts Proliferation and Differentiation by Targeting PRRX1
复制标题

DOI:
10.3389/fgene.2018.00577
复制
发表时间:
2018-12-04
影响因子:
3.7
通讯作者:
Nie, Qinghua
Nie, Qinghua
中科院分区:
生物学3区
文献类型:
--
作者:
Guo, Lijin;Huang, Weiling;Nie, Qinghua

文献摘要

被引文献

相似文献

非编码RNA在骨骼肌的生长和发育中发挥调节作用。我们之前的研究表明 gga-mir-133a-3p 是调节骨骼肌成肌细胞增殖和分化的潜在候选者。本研究的目的是揭示gga-mir-133a-3p在鸡成肌细胞增殖和分化中的调控机制。通过检测细胞增殖活性、细胞周期进程和EdU,我们发现gga-mir-133a-3p可以显着抑制成肌细胞的增殖。在成肌分化过程中,gga-mir-133a-3p上调,而gga-mir-133a-3p能显着促进分化相关肌源性因子上调,说明gga-mir-133a-3p能够促进成肌细胞的分化。转录水平和蛋白水平的验证证明gga-mir-133a-3p可以抑制PRRX1的表达,双荧光素酶实验也显示了它们的直接靶向关系。相应地,PRRX1能够显着促进成肌细胞增殖并抑制成肌细胞分化。在我们的研究中,我们证实gga-mir-133a-3p通过靶向PRRX1参与成肌细胞增殖和分化的调节。
Non-coding RNAs play a regulatory role in the growth and development of skeletal muscle. Our previous study suggested that gga-mir-133a-3p was a potential candidate for regulating myoblast proliferation and differentiation in skeletal muscle. The purpose of our study was to reveal the regulatory mechanism of gga-mir-133a-3p in the proliferation and differentiation of chicken myoblasts. Through the detection of cell proliferation activity, cell cycle progression and EdU, we found that gga-mir-133a-3p can significantly inhibit the proliferation of myoblasts. In the process of myogenic differentiation, gga-mir-133a-3p is up-regulated, while gga-mir-133a-3p can significantly promote the up-regulation of differentiation-related muscle-derived factors, indicating that gga-mir-133a-3p can promote the differentiation of myoblasts. Validation at the transcriptional level and protein level proved that gga-mir-133a-3p can inhibit the expression of PRRX1, and the dual-luciferase assay also showed their direct targeting relationship. Correspondingly, PRRX1 can significantly promote myoblast proliferation and inhibit myoblast differentiation. In our study, we confirmed that gga-mir-133a-3p participates in the regulation of proliferation and differentiation of myoblasts by targeting PRRX1.